Bács-Kiskun Megyei Kórház

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

François‐Clément Bidard, Virginia Kaklamani, Patrick Neven et al. · Journal of Clinical Oncology · 2022 · 626 citations · Full text

EULAR definition of difficult-to-treat rheumatoid arthritis

György Nagy, Nadia M T Roodenrijs, Paco M J Welsing et al. · Annals of the Rheumatic Diseases · 2020 · 486 citations · Full text

Randomized phase III study 306

Gregory L. Krauss, José M. Serratosa, Vicente Villanueva et al. · Neurology · 2012 · 424 citations

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

Arvind Dasari, Sara Lonardi, Rocio García‐Carbonero et al. · The Lancet · 2023 · 279 citations · Full text

Oncology, Gastrointestinal Oncology, Colorectal Cancer +6

Prospective, Multicentre, Nationwide Clinical Data from 600 Cases of Acute Pancreatitis

Andrea Párniczky, Balázs Kui, Andrea Szentesi et al. · PLoS ONE · 2016 · 252 citations · Full text